Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
Journals
IJERPH
Special Issues
Competitive Advantage Strategies for Healthcare Industry
ijerph-logo
Submit to IJERPH Review for IJERPH Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Competitive Advantage Strategies for Healthcare Industry

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Health Care Sciences & Services".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 15505

Special Issue Editors

Prof. Dr. Munjae Lee

E-Mail Website
Guest Editor
Department of Medical Humanities and Social Medicine, Ajou University School of Medicine, Suwon 16499, Republic of Korea
Interests: healthcare management; medical device industry; digital healthcare; technology commercialization; health policy
Special Issues, Collections and Topics in MDPI journals
Dr. Kyu-sung Lee

E-Mail Website
Guest Editor
Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul 06351, Republic of Korea
Interests: community care; health management; healthcare strategy; benign prostatic hyperplasia

Special Issue Information

The healthcare industry is an aggregation and integration of sectors within the economic system that provides goods and services to treat patients with curative, preventive, rehabilitative, and palliative care. It includes the generation and commercialization of goods and services for maintaining and re-establishing health. The modern healthcare industry includes three essential branches, services, products, and finance, and may be divided into many sectors and categories. The industry depends on interdisciplinary teams of trained professionals and paraprofessionals to meet the health needs of individuals and populations.

The main objective of this Special Issue is to advance the fields of the healthcare industry and innovation management. Thus, papers submitted for the Special Issue should empirically or quantitatively address the valuable implications of the healthcare industry.

Dr. Munjae Lee
Dr. Kyu-sung Lee
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • strategy 
  • healthcare industry 
  • medical device industry 
  • pharmaceutical industry 
  • biotechnology 
  • digital health 
  • health management 
  • interdisciplinary

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

14 pages, 760 KiB  
Article
Innovative Culture and Firm Performance of Medical Device Companies: Mediating Effects of Investment in Education and Training
by Jeong-min Ryu, Sewon Park, Yoonseo Park, Jeongwon Park and Munjae Lee
Int. J. Environ. Res. Public Health 2021, 18(17), 8926; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18178926 - 25 Aug 2021
Cited by 3 | Viewed by 2431
Abstract
This research explored the mediating effect of investment in education and training relating to the innovative culture and organizational performance of medical device companies. We used the Human Capital Corporate Panel data provided by the Korea Vocational Competency Development Institute. In the industrial [...] Read more.
This research explored the mediating effect of investment in education and training relating to the innovative culture and organizational performance of medical device companies. We used the Human Capital Corporate Panel data provided by the Korea Vocational Competency Development Institute. In the industrial classification system of panel data, the industries related to medical devices were extracted and conclusively analyzed for 8629 workers and 368 companies. The independent and dependent variables were innovative culture and corporation performance, respectively. Investment in training and education was a mediating variable between the independent and dependent variables. Quantitative data were analyzed using SPSS software. A higher level of organizational satisfaction emerged in an innovative culture. Innovative culture positively affected organizational satisfaction. Further, investment in education and training to promote an innovative culture positively affected organizational satisfaction. Medical device companies should improve their performance by creating an innovative culture. Full article
(This article belongs to the Special Issue Competitive Advantage Strategies for Healthcare Industry)
►▼ Show Figures

Figure 1

16 pages, 844 KiB  
Article
Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies
by Alberto A. López-Toro, Eva María Sánchez-Teba, María Dolores Benítez-Márquez and Mercedes Rodríguez-Fernández
Int. J. Environ. Res. Public Health 2021, 18(9), 4556; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18094556 - 25 Apr 2021
Cited by 19 | Viewed by 6276
Abstract
The pharmaceutical industry, concerned about the impact of its activity, has integrated responsible principles and practices with a view to improving its sustainable and financial performance. This study analyzes the relationship between environmental, social, governance, and controversy indicators and financial performance, measured through [...] Read more.
The pharmaceutical industry, concerned about the impact of its activity, has integrated responsible principles and practices with a view to improving its sustainable and financial performance. This study analyzes the relationship between environmental, social, governance, and controversy indicators and financial performance, measured through return on equity (ROA), return on assets (ROE), and Tobin’s Q, which are applied to the listed companies in the Nasdaq US Smart Pharmaceuticals Index. This index is composed of 30 international companies with a presence at the global level. All the data have been extracted from the Thomson Reuters database. The analysis was performed using structural equation modeling implemented with partial least squares. The results confirm the positive relationship between the construct composed of environmental, social, and governance (ESG) indicators and the aforementioned financial ratios. Additionally, a positive relationship of the controversy indicator with Tobin’s Q is supported. This suggests that the pharmaceutical multinationals focus their investments in sustainability on ESG and pay attention to controversies to boost the visibility of the company and thus increase its value. These conclusions confirm that investing in ESG is a profitable strategy. It is also relevant for managers as it increases the profits and the market value of multinational pharmaceutical companies. Full article
(This article belongs to the Special Issue Competitive Advantage Strategies for Healthcare Industry)
►▼ Show Figures

Figure 1

18 pages, 406 KiB  
Article
Administration of Strategic Agreements in Public Hospitals: Considerations to Enhance the Quality and Sustainability of Mergers and Acquisitions
by Javier Cerezo-Espinosa de los Monteros, Antonio Castro-Torres, Juan Gómez-Salgado, Javier Fagundo-Rivera, Carlos Gómez-Salgado and Valle Coronado-Vázquez
Int. J. Environ. Res. Public Health 2021, 18(8), 4051; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18084051 - 12 Apr 2021
Cited by 4 | Viewed by 2908
Abstract
Merger processes between hospitals have high benefit potential for patients, staff and managers. This integration of health centres can improve the quality and safety in patient care. Additionally, cooperative processes enhance the sustainability of the health system, by increasing team spirit, giving innovative [...] Read more.
Merger processes between hospitals have high benefit potential for patients, staff and managers. This integration of health centres can improve the quality and safety in patient care. Additionally, cooperative processes enhance the sustainability of the health system, by increasing team spirit, giving innovative ideas and improving staff satisfaction. In this article, the critical factors for successful hospital mergers and acquisitions in the Public Health System were considered to develop a brief guide to help with the organisation of a merger process. Five sections were designed: Strategic administration and objectives, Staff management, New hospital complex structure, Processes and Results. This guide facilitates the communication between a variety of stakeholders, thus improving the engagement between all members of the new healthcare system. This could be particularly important for countries with large regional variance in the organisation of health care and resources. Full article
(This article belongs to the Special Issue Competitive Advantage Strategies for Healthcare Industry)
20 pages, 654 KiB  
Article
Competitive Revenue Strategies in the Medical Consumables Industry: Evidence from Human Resources, Research and Development Expenses and Industry Life Cycle
by Jianxiong Chen and Chung-Cheng Yang
Int. J. Environ. Res. Public Health 2021, 18(6), 3180; https://0-doi-org.brum.beds.ac.uk/10.3390/ijerph18063180 - 19 Mar 2021
Cited by 7 | Viewed by 2595
Abstract
This study attempted to explore the competitive advantage strategies of the medical consumables industry (MCI) from the perspectives of human resources, research and development (R&D) and the industry life cycle. As one of the essential branches of modern medical device industry, the MCI [...] Read more.
This study attempted to explore the competitive advantage strategies of the medical consumables industry (MCI) from the perspectives of human resources, research and development (R&D) and the industry life cycle. As one of the essential branches of modern medical device industry, the MCI has developed rapidly in recent years as global demand for medical consumables has shown continual growth, but it also faces market uncertainty. This study took Taiwan’s small/medium medical consumables enterprises (SMMCEs) as a sample, and used the translog revenue function to study the competitive advantage of the MCI through human resource and R&D investment strategies and the stage characteristics of the industry life cycle curve. The results showed that the various human resources and R&D expenses of the small/medium medical consumables industry (SMMCI) can interact with each other to influence total revenue and that the SMMCI needs more varied types of human resources to enhance its competitive advantage. The total revenue of the SMMCI decreased as education inputs rose, but it increased along with increases in the number of employee and R&D inputs. Observed from the life cycle curve of the SMMCI, total revenue increased rapidly during the startup and growth stages, increased slowly during the maturity stage, and decreased during the decline stage. Finally, we put forward competitive advantage strategies and management suggestions for medical consumables enterprises (MCEs). We are the first to document the life cycle curve and competitive advantage strategies of the MCI, thereby contributing to the related literature. Full article
(This article belongs to the Special Issue Competitive Advantage Strategies for Healthcare Industry)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop